Clinically relevant efficacy of insulin therapy in patients with type 2 diabetes.
Faculty of PoitiersDepartment of General Practice, Poitiers, France.
Rémy
R
Boussageon
School of Pharmacy, Memorial University of Newfoundland, St. John's, Newfoundland and Labrador, Canada.
John-Michael
JM
Gamble
Lyon University, Lyon, France - CHU Lyon, Louis Pradel Hospital, Clinical pharmacology, Lyon, France - CNRS, UMR5558, Lyon, France.
François
F
Gueyffier
Inserm, Clinical Investigation Centre (CIC201), Lyon - Lyon University, Lyon, France - CHU Lyon, Louis Pradel Hospital, Clinical pharmacology, Lyon, France - CNRS, UMR5558, Lyon, France.
Catherine
C
Cornu
D002986:Clinical Trials as Topic; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007328:Insulin / Q000627:therapeutic use*; D018802:Patient-Centered Care; D016896:Treatment Outcome
D007004:Hypoglycemic Agents; D007328:Insulin